🌱 KidneyEnergy.com

← brief for 2026-08-26 · Slowing decline

Outcomes from the International Society of Nephrology Forum on Complement Therapeutics in C3G & IgAN

Paper No results yet Not peer reviewed

Key takeaways

Kidney specialists met to review drugs that block complement, a part of the immune system that can attack the kidney's filters. In C3 glomerulopathy and a related filter disease, overactive complement is the main cause. In IgA nephropathy it plays a smaller, second-hand role in the damage. Recent trials of these drugs have gone well, but this item is a meeting summary and reports no new results itself.

Source

Paper · Kidney International · 2026-08-26
https://www.kidney-international.org/article/S0085-2538(26)00711-8/fulltext?rss=yes